Squarepoint
CABA icon

Squarepoint’s Cabaletta Bio CABA Stock Holding History

Squarepoint’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-144,681
Closed -$389K – 4442
2026
Q1 		$389K Sell
144,681
-4,413
-3% -$12.3K ﹤0.01% 3509
2025
Q4 		$327K Buy
149,094
+137,226
+1,156% +$340K ﹤0.01% 3535
2025
Q3 		$27.8K Sell
11,868
-59,573
-83% -$102K ﹤0.01% 4270
2025
Q2 		$109K Buy
+71,441
New +$111K ﹤0.01% 4151
2025
Q1 		– Sell
-54,949
Closed -$125K – 4640
2024
Q4 		$125K Sell
54,949
-102,046
-65% -$358K ﹤0.01% 4642
2024
Q3 		$741K Sell
156,995
-158,384
-50% -$916K ﹤0.01% 2827
2024
Q2 		$2.36M Buy
315,379
+272,948
+643% +$3.35M ﹤0.01% 1928
2024
Q1 		$724K Buy
42,431
+18,798
+80% +$403K ﹤0.01% 2813
2023
Q4 		$536K Buy
23,633
+4,341
+23% +$73K ﹤0.01% 2959
2023
Q3 		$294K Buy
19,292
+8,873
+85% +$121K ﹤0.01% 3180
2023
Q2 		$135K Sell
10,419
-46,645
-82% -$506K ﹤0.01% 3309
2023
Q1 		$472K Buy
+57,064
New +$534K ﹤0.01% 2337
2021
Q2 		– Sell
-27,926
Closed -$310K – 3254
2021
Q1 		$310K Sell
27,926
-2,529
-8% -$30.9K ﹤0.01% 2369
2020
Q4 		$380K Sell
30,455
-22,844
-43% -$296K ﹤0.01% 2028
2020
Q3 		$578K Sell
53,299
-1,254
-2% -$14.4K 0.01% 1324
2020
Q2 		$608K Buy
54,553
+42,016
+335% +$322K 0.01% 1197
2020
Q1 		$92K Buy
+12,537
New +$172K ﹤0.01% 1655

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Squarepoint's CABA Position: Q2 2026 in Review

Squarepoint sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 144,681 shares — an estimated $389K sold.

Squarepoint first reported a position in CABA in Q1 2020 and held it in 17 quarters. The position peaked at $2.36M in Q2 2024. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Squarepoint reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 144,681 Cabaletta Bio shares in Q2 2026, an estimated $389K.
  • Squarepoint first reported a position in Cabaletta Bio in Q1 2020 and held it in 17 quarters.
  • Squarepoint's Cabaletta Bio position peaked at $2.36M in Q2 2024.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.